Business

WRAP Retail Offer for up to £1.5 million

ImmuPharma PLC is launching a WRAP Retail Offer to raise up to £1.5 million through the issuance of 25,000,000 new ordinary shares at 6.0 pence per share. This offer is in addition to a proposed subscription aiming to raise approximately £7.5 million at the same price, representing a discount to the previous day's closing price. The proceeds from both the retail offer and the subscription will be used for the same purposes, and completion of the retail offer is conditional on the subscription's completion. Shareholder approval is required for both, with admission to trading anticipated on April 8, 2026. Disclaimer*

articleImmupharma PlcMarch 17, 20263/company/immupharma-plc/news/wrap-retail-offer-for-up-to-pound15-million
WRAP Retail Offer for up to £1.5 million

About this update from Immupharma Plc

[{"type":"text","content":"\n\nNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, OR INTO OR WITHIN THE UNITED STATES, AUSTRALIA, NEW ZEALAND, CANADA, SOUTH AFRICA OR JAPAN, OR ANY MEMBER STATE OF THE EEA, OR ANY OTHER JURISDICTION WHERE, OR TO ANY OTHER PERSON TO WHOM, TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE LAW OR REGULATION. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.\n \nTHIS ANNOUNCEMENT AMOUNTS TO A FINANCIAL PROMOTION FOR THE PURPOSES OF SECTION 21 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (\"FSMA\") AND HAS BEEN APPROVED BY WINTERFLOOD SECURITIES LIMITED WHICH IS AUTHORISED AND REGULATED BY THE FINANCIAL CONDUCT AUTHORITY (FRN 141455).\n \n \n17 March 2026\n \nImmuPharma PLC\n(\"ImmuPharma\" or the \"Company\")\n \nWRAP Retail Offer for up to £1.5 million\n \nImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, is pleased to announce a retail offer via the Winterflood Retail Access Platform (\"WRAP\") to raise up to £1.5 million (the \"WRAP Retail Offer\") through the issue of new ordinary shares of 1 penny each in the capital of the Company (\"Ordinary Shares\"). Under the WRAP Retail Offer 25,000,000 new Ordinary Shares (the \"WRAP Retail Offer Shares\") will be made available at a price of 6.0 pence per share.\n \nIn addition to the WRAP Retail Offer and as announced at 7.00 a.m. on 17 March 2026, the Company is also proposing a subscription of new Ordinary Shares (the \"Subscription Shares\" and together with the WRAP Retail Offer Shares, the \"New Ordinary Shares\") to raise approximately £7.5 million (before expenses) at a price of 6.0 pence per Subscription Share (the \"Issue Price\"). The Issue Price represents a discount of approximately 13.7 per cent. to the mid-market closing price of an Ordinary Share on 16 March 2026 (being the latest practicable date prior to this announcement). The issue price of the WRAP Retail Offer Shares is equal to the Issue Price.\n \nA separate announcement has been made regarding the Subscription and its terms and sets out the reasons for the Subscription and use of proceeds.  The proceeds of the WRAP Retail Offer will be utilised in the same way as the proceeds of the Subscription.\n \nFor the avoidance of doubt, the WRAP Retail Offer is no...

More updates from Immupharma Plc